RYH

Guggenheim S&P 500® Equal Weight Health Care ETF
NAV $136.54
Change $1.92 | 1.43%
As Of 10/30/14

Investment Objectives

Seeks to replicate as closely as possible, before fees and expenses, the performance of the S&P 500 Equal Weight Index Health Care.


Net Asset Value

Net Asset Value $136.54
Change $1.92 | 1.43%


Summary


Ticker RYH
CUSIP 78355W841
Asset Class Sector
Inception Date 11/1/06
Gross Expense Ratio 0.40%
IOPV Ticker RYH.IV
Related Index Ticker S35
Investment Adviser Security Investors, LLC.
Distributor Guggenheim Funds Distributors, LLC.


Profile

Volume 34,325
Last Sale Price $136.43
52-Week Range $136.54 / $103.76
Shares Outstanding 2,800,000
Total Net Assets $382,324,953.95

Market Close

Market Price $136.43
Premium / Discount -$0.11
Change $1.80 | 1.34%
High / Low $136.75 / $134.00


Historical Market Closes to NAV

  Days % of Total Days
Premium 990 49.20%
Discount 914 45.43%
Equal to NAV 108 5.37%
Total 2,012 100%


Characteristics

Number of Stocks 55
Return on Equity (quarterly 9/30/14) 17.85%
Price to Earning (P/E) 26.39
Price to Book (P/B) 3.62
Dividend Amount $0.14
Ex-Dividend Date N/A

Risk

As of 9/30/14
Standard Deviation Sharpe Ratio Beta R-Squared
10.60 2.70 1.03 99.41

Risk Definitions

Standard Deviation A statistical measure of the historical volatility of an investment, computed using 36 monthly returns. More generally, a measure of the extent to which numbers are spread around their average. The higher the number, the more volatility is to be expected.
Sharpe Ratio A risk-adjusted measure developed by William F. Sharpe, calculated using standard deviation and excess return to determine reward per unit of risk. The higher the Sharpe ratio, the better the fund's risk-adjusted performance.
Beta Beta is a statistical measure of volatility relative to the overall market, usually the S&P 500. A positive beta indicates movement in the same direction as the market, while a negative beta indicates movement inverse to the market. Beta for the market is generally considered to be 1. A beta above 1 or below -1 indicates more volatility than the market. A beta between 1 to -1 indicates less volatility than the market.
R-Squared
A measurement of how closely an investment's performance correlates with the performance of a benchmark, such as the S&P 500, and thus a measurement of what portion of its performance may be explained by the performance of the overall market or index. Values for R-squared range from 0 to 100, where 0 indicates no correlation and 100 indicates perfect correlation.

Overview

as of 10/30/2014
Total Assets $382,324,954
Number of Stocks 55
Percent Stock 99.78%
Percent Cash / Other 0.22%

Sectors / Industries

as of 10/30/14

Holdings

as of 10/30/14

Security Name Ticker Shares
Held
Market
Value
% of Net Assets Sector / Industry
CAREFUSION CORP CFN 141,765 $8,154,322.80 2.13% Health Care Equipment & Supplies
EDWARDS LIFESCIENCES CORP EW 65,977 $7,935,713.56 2.08% Health Care Equipment & Supplies
VERTEX PHARMACEUTICALS VRTX 70,723 $7,839,644.55 2.05% Biotechnology
ALEXION PHARMACEUTICALS I ALXN 40,417 $7,797,651.81 2.04% Biotechnology
BRISTOL MYERS SQUIBB CO BMY 130,850 $7,717,533.00 2.02% Pharmaceuticals
AMGEN INC. AMGN 47,694 $7,706,396.52 2.02% Biotechnology
CELGENE CORPORATION CELG 71,859 $7,684,601.46 2.01% Biotechnology
REGENERON PHARMACEUTICALS REGN 19,004 $7,464,771.20 1.95% Biotechnology
BECTON DICKINSON & CO BDX 57,835 $7,375,119.20 1.93% Health Care Equipment & Supplies
ALLERGAN INC AGN 38,857 $7,361,070.08 1.93% Pharmaceuticals
PERRIGO COMPANY PRGO 45,513 $7,342,612.29 1.92% Pharmaceuticals
MYLAN INC. MYL 139,748 $7,318,602.76 1.91% Pharmaceuticals
GILEAD SCIENCES, INC. GILD 63,444 $7,246,573.68 1.90% Biotechnology
AMERISOURCEBERGEN CORP ABC 85,299 $7,236,767.16 1.89% Health Care Providers & Services
UNITEDHEALTH GROUP INC. UNH 76,312 $7,164,170.56 1.87% Health Care Providers & Services
C.R. BARD, INC. BCR 44,457 $7,157,132.43 1.87% Health Care Equipment & Supplies
WATERS CORPORATION WAT 64,616 $7,146,529.60 1.87% Life Sciences Tools & Services
MALLINCKRODT PLC MNK 76,251 $7,078,380.33 1.85% Pharmaceuticals
DENTSPLY INTERNATIONAL XRAY 140,675 $7,046,410.75 1.84% Health Care Equipment & Supplies
HUMANA, INC. HUM 51,275 $7,033,904.50 1.84% Health Care Providers & Services
CERNER CORPORATION CERN 111,941 $7,013,103.65 1.83% Health Care Technology
MCKESSON CORPORATION MCK 34,170 $6,952,911.60 1.82% Health Care Providers & Services
ABBVIE INC-W/I ABBV 113,624 $6,951,516.32 1.82% Pharmaceuticals
BOSTON SCIENTIFIC CORP BSX 526,125 $6,934,327.50 1.81% Health Care Equipment & Supplies
CIGNA CORPORATION CI 71,236 $6,917,015.60 1.81% Health Care Providers & Services
PATTERSON COS INC PDCO 162,105 $6,912,157.20 1.81% Health Care Providers & Services
DAVITA, INC DVA 88,788 $6,891,724.56 1.80% Health Care Providers & Services
STRYKER CORP SYK 78,798 $6,858,577.92 1.79% Health Care Equipment & Supplies
ZIMMER HOLDINGS INC ZMH 62,670 $6,848,577.60 1.79% Health Care Equipment & Supplies
WELLPOINT, INC. WLP 55,441 $6,835,320.89 1.79% Health Care Providers & Services
ACTAVIS PLC ACT 28,060 $6,824,472.60 1.78% Pharmaceuticals
CARDINAL HEALTH, INC. CAH 87,233 $6,820,748.27 1.78% Health Care Providers & Services
MEDTRONIC, INC. MDT 100,882 $6,802,473.26 1.78% Health Care Equipment & Supplies
ZOETIS INC ZTS 181,773 $6,783,768.36 1.77% Pharmaceuticals
HOSPIRA INC HSP 124,959 $6,777,776.16 1.77% Pharmaceuticals
EXPRESS SCRIPTS HLDGS ESRX 89,191 $6,737,488.14 1.76% Health Care Providers & Services
JOHNSON & JOHNSON JNJ 62,886 $6,731,317.44 1.76% Pharmaceuticals
ELI LILLY & COMPANY LLY 100,759 $6,730,701.20 1.76% Pharmaceuticals
ABBOTT LABORATORIES ABT 154,562 $6,721,901.38 1.76% Health Care Equipment & Supplies
INTUITIVE SURGICAL, INC. ISRG 13,681 $6,703,690.00 1.75% Health Care Equipment & Supplies
ST. JUDE MEDICAL INC. STJ 104,258 $6,701,704.24 1.75% Health Care Equipment & Supplies
PFIZER INC PFE 223,465 $6,668,195.60 1.74% Pharmaceuticals
QUEST DIAGNOSTICS, INC. DGX 105,022 $6,666,796.56 1.74% Health Care Providers & Services
COVIDIEN PLC COV 72,532 $6,644,656.52 1.74% Health Care Equipment & Supplies
LABORATORY CORP OF AMERIC LH 61,839 $6,640,890.21 1.74% Health Care Providers & Services
BIOGEN IDEC, INC. BIIB 20,337 $6,528,177.00 1.71% Biotechnology
VARIAN MEDICAL SYSTEMS IN VAR 77,072 $6,474,048.00 1.69% Health Care Equipment & Supplies
AETNA INC AET 80,007 $6,448,564.20 1.69% Health Care Providers & Services
PERKINELMER PKI 147,225 $6,388,092.75 1.67% Life Sciences Tools & Services
MERCK & COMPANY, INC. MRK 110,437 $6,329,144.47 1.66% Pharmaceuticals
THERMO FISHER SCIENTIFIC TMO 53,346 $6,219,610.14 1.63% Life Sciences Tools & Services
BAXTER INTERNATIONAL BAX 88,040 $6,168,082.40 1.61% Health Care Equipment & Supplies
AGILENT TECHNOLOGIES, INC A 112,227 $6,096,170.64 1.59% Life Sciences Tools & Services
UNIVERSAL HEALTH SERVICES UHS 58,872 $6,043,799.52 1.58% Health Care Providers & Services
TENET HEALTHCARE CORP THC 106,885 $5,924,635.55 1.55% Health Care Providers & Services
FEDERATED US TREAS CASH RESERVE INSTITUTIONAL 673,747 $673,747.44 0.18% na

Disclosure

Performance displayed represents past performance, which is no guarantee of future results. Investment returns and principal value will fluctuate so that when shares are redeemed, they may be worth more or less than original cost. Total returns reflect the reinvestment of all dividends. Current performance may be lower or higher than the performance data quoted. For up-to-date fund performance, including performance current to the most recent month-end, please visit the ETF performance page. ETFs are subject to third party transaction fees/commissions. Net asset value (NAV) is calculated by subtracting total liabilities from total assets, then dividing by the number of shares outstanding. Market close is the last price at which shares are traded. Fund shares may trade at, above or below NAV. For additional information, see the fund’s prospectus.

Performance results for periods under one year are short-term and may not provide an adequate basis for evaluating the performance potential of the fund over varying market conditions or economic cycles.

Sector funds may not be suitable for all investors. Investing in sector funds is more volatile than investing in broadly diversified funds, as there is a greater risk due to the concentration of the funds' holdings in issuers of similar offerings. Guggenheim Investment Equal Weight ETFs may not be suitable for all investors. Investment returns and principal value will fluctuate so that when shares are redeemed, they may be worth more or less than original cost. Most investors will also incur customary brokerage commissions when buying or selling shares of an ETF. Investments in securities are subject to market risks that may cause their prices to fluctuate over time. Please review a prospectus carefully for more information of the risks associated with each ETF.

Fund data is subject to change on a daily basis.

Composition is subject to change. Information provided is for illustration purposes only and may not reflect current investments by the fund. Referenced companies are not affiliated with Guggenheim Investments and Guggenheim Investments does not sponsor, endorse, sell or promote the referenced companies.

“Standard & Poor’s®”, “S&P®”, “S&P 500®”, “Standard & Poor’s 500”, “500”, “S&P MidCap 400” and “S&P SmallCap 600” are trademarks of Standard & Poor’s, LLC and have been licensed for use by Guggenheim Investments and its affiliates. Citigroup is a trademark of Citigroup Global Markets Inc. and has been licensed for use by Standard & Poor’s. The product is not sponsored, endorsed, sold or promoted by Standard & Poor’s, and neither Standard & Poor’s nor Citigroup Global Markets Inc. makes no representation regarding the advisability of investing in the product.
 

Read a prospectus and summary prospectus (if available) carefully before investing. It contains the investment objectives, risks, charges, expenses and other information, which should be considered carefully before investing. To obtain a prospectus and summary prospectus (if available) click here or contact us.

Guggenheim Investments represents the investment management businesses of Guggenheim Partners, LLC ("Guggenheim"), which includes Security Investors, LLC ("SI"), Guggenheim Funds Investment Advisors, LLC, ("GFIA") and Guggenheim Partners Investment Management ("GPIM") the investment advisers to the referenced funds. Securities offered through Guggenheim Funds Distributors, LLC, an affiliate of Guggenheim, SI, GFIA and GPIM.

Guggenheim

Subscribe to Perspectives

 

©2014 Guggenheim Investments. All Rights Reserved.

• Not FDIC Insured • No Bank Guarantee • May Lose Value